{
  "schemaVersion": 1,
  "id": "research-249",
  "slug": "249-why-a-type-1-diabetes-study-measured-c-peptide",
  "title": "Why a type 1 diabetes study measured C-peptide",
  "catalogLabel": "Liraglutide",
  "productCollection": "https://heritagebiolabs.com/research-library/products/liraglutide",
  "productHandles": [
    "liraglutide-702"
  ],
  "productUrls": [
    "https://heritagebiolabs.com/product/liraglutide-702"
  ],
  "readingFocus": "Methods & identity",
  "readingFocusNote": "Reading focus is a navigational tag, not an evidence grade.",
  "wordCount": 306,
  "sourceYears": [
    2025,
    2026
  ],
  "paragraphs": [
    "A peptide is a short amino-acid chain whose links are peptide bonds. Some peptides act as signals, while others can be measured as clues to what a cell produces. Liraglutide is a modified GLP-1 receptor agonist peptide. Its effects on blood glucose in type 2 diabetes led researchers to ask a narrower question in people with long-standing type 1 diabetes. Could the medicine preserve any insulin-making function that remained? [1, 2]",
    "When pancreatic beta cells make insulin, they split a precursor into insulin and a separate short chain called C-peptide. A C-peptide measurement can help researchers estimate how much insulin the body is making itself. The study enrolled 18 adults with type 1 diabetes who still had measurable fasting C-peptide. They were randomly assigned to liraglutide or placebo for 52 weeks. The investigators measured C-peptide after a standardized meal to see how the remaining beta cells responded to food. [1]",
    "The primary outcome compared the change in stimulated C-peptide at week 52. The researchers did not find that liraglutide improved that outcome compared with placebo. They also examined results across several visits, including a visit after treatment ended, in an exploratory analysis. In that analysis C-peptide fell more steeply in the liraglutide group. Because the latter analysis was exploratory and the trial was very small, it provides a question for further study rather than a precise estimate of harm. [1]",
    "This trial concerns residual beta-cell function in adults with long-standing type 1 diabetes. The U.S. Victoza label describes a type 2 diabetes indication for glycemic control. The groups and the biological questions differ. A change in HbA1c in type 2 diabetes would not tell researchers how much insulin a person with type 1 diabetes can still produce. By measuring C-peptide after a meal, the investigators directly tested the particular question that motivated their trial. [1, 2]"
  ],
  "sources": [
    {
      "number": 1,
      "citation": "J. Caballero-Corbalán et al. Liraglutide and Βeta-Cell Function in Young Adults With Long-Standing Type 1 Diabetes and Residual C-Peptide: A Blinded, Randomized Controlled Trial. Diabetes, Obesity and Metabolism (publication 2026-08-13).",
      "url": "https://pubmed.ncbi.nlm.nih.gov/42595732/"
    },
    {
      "number": 2,
      "citation": "U.S. Food and Drug Administration. VICTOZA (liraglutide) injection, prescribing information. Drugs@FDA (publication 2025-10).",
      "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022341s046lbl.pdf"
    }
  ],
  "canonicalUrl": "https://heritagebiolabs.com/research-library/articles/249-why-a-type-1-diabetes-study-measured-c-peptide",
  "markdownUrl": "https://heritagebiolabs.com/research-library/data/articles/249-why-a-type-1-diabetes-study-measured-c-peptide.md",
  "jsonUrl": "https://heritagebiolabs.com/research-library/data/articles/249-why-a-type-1-diabetes-study-measured-c-peptide.json",
  "provenance": {
    "sourceArchive": "Peptide Research Articles - All 82 Volumes.zip",
    "sourceArchiveSha256": "9796bec477cbe2f8017dda81c7e58260985a13bdda1f934e8eb8d0549c2cada5",
    "sourceVolume": "Peptide Research Articles 050 - Lipopeptide and Liraglutide.docx",
    "sourceArticleNumber": 249,
    "contentSha256": "2e02ed5d52b694edce9eba52c8ab8c2c12af2306fe22b9f0a36c2c0fe5bc4281",
    "statement": "Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed."
  },
  "scope": "Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend."
}
